http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S56113741-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6cfc033f059d282fcd915bc8be2ae53f
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C229-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-157
filingDate 1980-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99fcd5ca7a8b91d1b23cac90ad3c2a96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f51770e38fc7dc4177ee3141be8919d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bfc693ae8b43c7c6cb8b90185518ba2
publicationDate 1981-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S56113741-A
titleOfInvention Preparation of crystal of acetylsalicylic acid salt
abstract PURPOSE: To obtain the titled crystal useful as an antipyretic, analgesic and antirheumatic agent, in high quality and processability, by reacting acetylsalicylic acid with an amino acid in a solvent system containing a specific solvent, and crystallizing the reaction product. n CONSTITUTION: Acetylsalicylic acid is made to react with an amino acid (e.g. dl- lysine) using an alcohol or its aqueous mixture, or acetone or its aquesous mixture as the reaction and crystallization solvent to obtain crystal of acetylsalicylic acid amino acid salt. When an aromatic hydrocarbon (e.g. benzene) is added to the reaction system, the size of the crystallized aspirin amino acid salt crystal is increased, and consequently, the filtration and washing of the crystal are facilitated, the hydrolysis of the product is prevented, and the drying is also facilitated. n COPYRIGHT: (C)1981,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012131824-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7449198-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2004507463-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6773724-B2
priorityDate 1980-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556224
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394110
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID241
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559219
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556976
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID866
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244

Total number of triples: 30.